Suppr超能文献

如果没有伊维菌素,我会在哪里?在非洲,利用社区导向伊维菌素治疗来实现收益。

Where would I be without ivermectin? Capturing the benefits of community-directed treatment with ivermectin in Africa.

机构信息

Department of Sociology/Anthropology, University of Nigeria, Nsukka, Enugu State, Nigeria.

出版信息

Trop Med Int Health. 2011 May;16(5):608-21. doi: 10.1111/j.1365-3156.2011.02735.x. Epub 2011 Mar 14.

Abstract

OBJECTIVES

To document peoples' perceptions of the benefits of taking ivermectin, as an important predictor of sustained compliance with long-term ivermectin treatment, and to identify the socio-demographic correlates of perceived benefits of ivermectin treatment.

METHODS

Multisite study in Cameroon, DRC, Nigeria and Uganda. A structured questionnaire was administered to 1600 persons randomly selected from household treatment records. Community leaders, community-directed drug distributors (CDDs) and health workers were interviewed using in-depth interview guides, while focus group discussions (FGDs) were held with community members to capture factors that reflected their perception of benefits of community-directed treatment with ivermectin (CDTI). Case histories of persons with special experiences with onchocerciasis were collected.

RESULTS

In this study, 84.7% of respondents indicated that ivermectin treatment has many benefits. The social benefits of CDTI included improved ability to work, peer acceptance and improved school attendance. Other individual benefits included self-respect/esteem, election to political office and improved relationship in the homes. The health benefits included improved skin texture and less ill health. Important demographic factors that influenced perception of the benefits of taking ivermectin, include marital status (P=0.012), age (P=0.029) and length of stay in onchocerciasis-endemic communities (P<0.001). Another factor was individual perception of susceptibility to onchocerciasis infection (P<0.0001).

CONCLUSION

A programmatic focus on the benefits of CDTI could provide a basis for motivating communities to comply with long-term treatment with ivermectin. The results illustrate the importance of capturing beneficiaries' perceptions towards CDTI as a resource for producing health education materials for increasing the sustainability ivermectin distribution in endemic countries.

摘要

目的

记录人们对服用伊维菌素益处的看法,因为这是对长期服用伊维菌素持续依从性的一个重要预测指标,并确定伊维菌素治疗益处的感知与社会人口学因素的相关性。

方法

在喀麦隆、刚果民主共和国、尼日利亚和乌干达进行的多地点研究。从家庭治疗记录中随机选择了 1600 人,对他们进行了结构化问卷调查。使用深入访谈指南对社区领导、社区定向药物分发员(CDD)和卫生工作者进行了访谈,同时与社区成员进行了焦点小组讨论(FGD),以了解反映他们对社区定向伊维菌素治疗(CDTI)益处的看法的因素。还收集了具有特殊盘尾丝虫病经验的个人的病例史。

结果

在这项研究中,84.7%的受访者表示伊维菌素治疗有很多益处。CDTI 的社会效益包括提高工作能力、被同龄人接受和提高入学率。其他个人益处包括自尊/尊重、当选政治职务和改善家庭关系。健康益处包括改善皮肤质地和减少疾病。影响人们对服用伊维菌素益处的看法的重要人口因素包括婚姻状况(P=0.012)、年龄(P=0.029)和在盘尾丝虫病流行社区的居住时间(P<0.001)。另一个因素是个人对感染盘尾丝虫病易感性的看法(P<0.0001)。

结论

关注 CDTI 的益处可以为激励社区遵守长期伊维菌素治疗提供基础。研究结果表明,捕捉受益人的看法对 CDTI 非常重要,这是为提高流行国家伊维菌素分发的可持续性而制作健康教育材料的资源。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验